Consultez votre mdecin ou pharmacien pour plus d'informations
Herein, we provide perspectives on the historical events and key experimental findings establishing the biology of GLP-1 as an insulin-stimulating glucoregulatory hormone
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases
When Novo Nordisk developed Liraglutide, it was originally intended to be a type 2 diabetes medication and was licensed for that purpose under the brand name Victoza
Denmark: Arne Astrup, Bjrn Richelsen, Kjeld Hermansen, Steen Madsbad
Values and leadership Model Omadas values by cultivating trust, seeking context, acting boldly, delivering results, succeeding together, and keeping the mission at the center of daily work